Impacts of Climate Change and Air Pollution on Neurologic Health, Disease, and Practice, A Scoping Review
Neurol 100:474-483, Louis,S.,et al, 2023
Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity
Ann Neurol 94:146-159, Giraldo,G.S.P.,et al, 2023
Unpacking the CNS Manifestations of Epstein-Barr Virus:An Imaging Perspective
AJNR 44:1002-1008, Soni,N.,et al, 2023
Neurologic Features in Severe SARS-CoV-2 Infection
NEJM 382:2268-2270, e110, , 2020
COVID-19: A Global Threat to the Nervous System
Ann Neurol 88:1-11, Koralnik, I.J. & Tyler, K.L., 2020
National Characteristics and Predictors of Neurology 30-day Readmissions
Neurol 86:669-675, Guterman, E.L.,et al, 2016
Zika Virus as a Cause of Neurologic Disorders
NEJM 374:1506-1509, Broutet, N.,et al, 2016
Neurologic Complications of Influenza A (H1N1)pdm09
Neurol 79:1474-1481, Khandaker,G.,et al, 2012
Spectrum of Neurologic Complications in Chronic Lymphocytic Leukemia
Clin Lymphoma Myeloma Leuk 12:164-179, Lopes da Silva, R., 2012
Arenaviruses: A Neurological Problem at Any Age
Ann Neurol 62:309-311, Gilden,D.H., 2007
Congenital Lymphocytic Choriomeningitis Virus Infection: Spectrum of Disease
Ann Neurol 62:347-355, Bonthius,D.J.,et al, 2007
Pediatric West Nile Virus Infection: Neurologic Disease Presentations During the 2002 Epidemic in Cuyaoga County, Ohio
Pediatr Infect Dis J 25:751-753, LeBeaud,A.D.,et al, 2006
Neurologic Aspects of Infections in International Travelers
The Neurologist 11:30-44, Han,M.H. &Zunt,J.R., 2005
West Nile Virus Infection in the United States
Arch Neurol 61:1190-1195, Tyler,K.L., 2004
West Nile Virus: A Primer for the Clinician
Ann Int Med 137:173-179, Petersen,L.R. &Marfin,A.A., 2002
Illness After International Travel
NEJM 347:505-516, Ryan,E.T.,et al, 2002
Epidemic West Nile Encephalitis, New York, 1999: Results of a Household-based Seroepidemiological Survey
Lancet 358:261-264,254, Mostashari,F.,et al, 2001
Neurological Manifestations of Dengue Infection
Lancet 355:1053-1059, Solomon,T.,et al, 2000
Incidence and Prevalence of Neurological Disorders Associated with HIV Since the Introduction of Highly Active Antiretroviral Therapy (HAART)
JNNP 69:376-380, Maschke,M. et al, 2000
Nomenclature and Research Case Definitions for Neurologic Manifestations of Human Immunodeficiency Virus-Type I (HIV-1) Infection
Neurol 41:778-785, , 1991